{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:06:07Z","timestamp":1764842767395,"version":"3.40.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,25]]},"abstract":"<jats:p>A clear bidirectional relationship exists between malignant cancers including breast cancer and different autoimmune diseases. However, none of the studies have assessed whether this association is causal and none have used Mendelian randomization for determining this relationship. This study therefore investigated the causal relationship between autoimmune diseases and breast cancer using the Mendelian randomization approach. Summary statistical data were obtained from genome-wide association studies to investigate the causal relationship between different autoimmune diseases including Graves\u2019 disease, Sj\u00f6gren\u2019s syndrome, Crohn disease, systemic sclerosis, and psoriasis and breast cancer risk. The results revealed no strong evidence to support the causal relationship between Graves disease (odds ratio [OR] = 0.9958; 95% confidence interval [CI]: 0.9982\u20131.0035), Sj\u00f6gren\u2019s syndrome (OR = 1.0018; 95% CI: 0.9950\u20131.0087), Crohn disease (OR = 2.1195, 95% CI: 0.1872\u201323.9978), systemic sclerosis (OR = 1.0024; 95% CI: 0.997\u20131.0079), and psoriasis (OR = 1.0016; 95% CI: 0.9913\u20131.0121) to breast cancer risk. A similar result was obtained in the reverse Mendelian randomization analysis. Our study provides evidence that autoimmune diseases might not have a causal relationship with breast cancer risk in the European population and concludes that shared genetic effects or environmental confounders.<\/jats:p>","DOI":"10.1097\/md.0000000000034612","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T22:02:58Z","timestamp":1693432978000},"page":"e34612","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Investigation of the causal relationship between breast cancer and autoimmune diseases: A bidirectional mendelian randomization study"],"prefix":"10.1097","volume":"102","author":[{"given":"Yuyang","family":"Lu","sequence":"first","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, P. R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9090-1667","authenticated-orcid":false,"given":"Li","family":"Ma","sequence":"additional","affiliation":[{"name":"The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, P. R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/9605439","article-title":"Global increase in breast cancer incidence: risk factors and preventive measures.","volume":"2022","author":"Kashyap","year":"2022","journal-title":"Biomed Res Int"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/039463200902200303","article-title":"Systemic sclerosis and cancer.","volume":"22","author":"Marasini","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.autrev.2017.07.022","article-title":"Cancer and autoimmune diseases.","volume":"16","author":"Giat","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/dyv071","article-title":"mendelian randomization studies: a review of the approaches used and the quality of reporting.","volume":"44","author":"Boef","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for mendelian randomization studies: subsample and 2-sample instrumental variable estimators.","volume":"178","author":"Pierce","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cei\/uxac065","article-title":"Immune cell\u2013antibody interactions in health and disease.","volume":"209","author":"Karagiannis","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"13086","DOI":"10.1002\/cam4.5989","article-title":"Survival in elderly patients with breast cancer with and without autoimmune disease.","volume":"12","author":"Dedousis","year":"2023","journal-title":"Cancer Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"898138","DOI":"10.3389\/fimmu.2022.898138","article-title":"is estrogen a missing culprit in thyroid eye disease? Sex steroid hormone homeostasis is key to other fibrogenic autoimmune diseases \u2013 why not this one?","volume":"13","author":"FitzPatrick","year":"2022","journal-title":"Front Immunol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","article-title":"The NHGRI-EBI GWAS catalog: knowledgebase and deposition resource.","volume":"51","author":"Sollis","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"R14-20250504","doi-asserted-by":"crossref","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and mendelian randomization: a review.","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/EDE.0b013e31821b506e","article-title":"The false-positive to false-negative ratio in epidemiologic studies.","volume":"22","author":"Ioannidis","year":"2011","journal-title":"Epidemiology"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"19313","DOI":"10.1073\/pnas.1313476110","article-title":"Revised standards for statistical evidence.","volume":"110","author":"Johnson","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ptj\/81.8.1464","article-title":"Sifting the evidence \u2013 what is wrong with significance tests?","volume":"81","author":"Sterne","year":"2001","journal-title":"Phys Ther"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"Supplement_2","key":"R21-20250504","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.1990","article-title":"Plasma lipids and risk of aortic valve stenosis: a mendelian randomization study.","volume":"41","author":"Nazarzadeh","year":"2020","journal-title":"Eur Heart J"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"103167","DOI":"10.1016\/j.autrev.2022.103167","article-title":"standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: data from the Spanish scleroderma registry (RESCLE).","volume":"21","author":"Carbonell","journal-title":"Autoimmun Rev"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.autrev.2013.09.006","article-title":"Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian rheumatologic center and a population-based cancer registry and review of the literature.","volume":"13","author":"Colaci","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"336","DOI":"10.21037\/gs-20-878","article-title":"Thyroid disease is associated with an increased risk of breast cancer: a systematic review and meta-analysis.","volume":"10","author":"Chen","year":"2021","journal-title":"Gland Surg"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2012.07.100","article-title":"Effect of autoimmune diseases on risk and survival in female cancers.","volume":"127","author":"Hemminki","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1046\/j.0022-202x.2001.01520.x","article-title":"Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden.","volume":"117","author":"Boffetta","year":"2001","journal-title":"J Investig Dermatol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/ajd.12889","article-title":"Psoriasis and cancer. an Australian\/New Zealand narrative.","volume":"60","author":"Rademaker","year":"2018","journal-title":"Australas J Dermatol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0190-9622(90)70152-8","article-title":"The prevalence of malignant tumors in patients with psoriasis.","volume":"22","author":"Lindel\u00f6f","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0039-1683923","article-title":"Crohn\u2019s disease and the risk of cancer.","volume":"32","author":"Carchman","year":"2019","journal-title":"Clin Colon Rectal Surg"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/CEJ.0000000000000667","article-title":"Inflammatory bowel disease and risk of breast cancer.","volume":"31","author":"Gong","year":"2021","journal-title":"Eur J Cancer Prev"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"e0222860","DOI":"10.1371\/journal.pone.0222860","article-title":"Risk of major autoimmune diseases in female breast cancer patients: a nationwide, population-based cohort study.","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12916-017-0915-4","article-title":"Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study.","volume":"15","author":"Yang","year":"2017","journal-title":"BMC Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jare.2016.04.001","article-title":"Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: a review.","volume":"7","author":"Zarkavelis","year":"2016","journal-title":"J Adv Res"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/bjd.15830","article-title":"Risk of cancer in patients with psoriasis on biological therapies: a systematic review.","volume":"178","author":"Peleva","year":"2017","journal-title":"Br J Dermatol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:03:31Z","timestamp":1746327811000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":34,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034612","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,8,25]]}}}